![]() | Up a level |
Reinmuth, Niels and Paz-Ares, Luis and Chen, Yuanbin and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and LI, Jun Ho and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nicolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan and Alt, Jürgen (2020) Caspian: Os Results from a Randomised Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Chemotherapy in ES-SCLC. Oncology Research and Treatment, V. 43 (s. 1). p. 115. ISSN 2296-5270 (Print); 2296-5262 (Online)
Reinmuth, Niels and Bryl, Maciej and Bondarenko, Igor and Syrigos, Kostas and Vladimirov, Vladimir and Zereu, Manuela and Bair, Angel H. and Hilton, Fiona and Liau, Katherine and Kasahara, Kazuo (2019) PF‑06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First‑Line Treatment for Advanced Non‑Squamous Non‑Small‑Cell Lung Cancer: A Randomized, Double‑Blind Study. BioDrugs. pp. 1-16. ISSN 1173-8804 (Print) 1179-190X (Online)